Novartis Cosentyx® shows encouraging results versus Humira®* from first-of-its-kind head-to-head trial in psoriatic arthritis

    NEXT STORY
    EyePoint Pharmaceuticals Secures New Patient Access Agreement with Vizient Inc. for DEXYCU®
    PREV STORY
    Blueberries Medical Partners with 12,000 Patient Health Clinic and Renowned Academic Foundation and Announces Final Closing of Over-Subscribed Private Placement
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Taconic Biosciences Announces New San Diego Location

    author_avatar
    NASDAQ Market News

    Immunophotonics, Inc. Announces First Patient Dosed in a Randomized, Controlled Breast Cancer Clinical Trial for inCVAX – A Novel Investigational Immuno-Oncology Therapy

    ST. LOUIS, Aug. 23, 2016 (GLOBE NEWSWIRE) -- Immunophotonics today announces that it has ...

    author_avatar
    NASDAQ Market News

    AB Science will present results from its Phase 3 AB07015 study in severe asthma at the 2020 American Thoracic Society International Conference

    author_avatar
    NASDAQ Market News